Isoleucyl-tRNA synthetase — Drug Target

All drugs that target Isoleucyl-tRNA synthetase — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Topical antibiotic · bacterial protein synthesis inhibitor

Marketed (2)

• BACTROBAN® Nasal ong · Lindenhofgruppe AG · Topical antibiotic · Infectious Disease
  Mupirocin is a topical antibiotic that inhibits bacterial protein synthesis by binding to isoleucyl-tRNA synthetase.
• Mupirocin Ointment [Treatment] · US Department of Veterans Affairs · Topical antibiotic · Infectious Disease / Dermatology
  Mupirocin inhibits bacterial protein synthesis by binding to isoleucyl-tRNA synthetase, preventing bacterial growth and reproduction.

Phase 3 pipeline (1)

• mupirocin 2% ointment · Philippine Dermatological Society · bacterial protein synthesis inhibitor · Dermatology
  Mupirocin 2% ointment works by inhibiting bacterial protein synthesis, specifically targeting isoleucyl-tRNA synthetase.